<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xml:lang="en" article-type="research-article" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<?release-delay 0|0?>
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">BR</journal-id>
<journal-title-group>
<journal-title>Biomedical Reports</journal-title>
</journal-title-group>
<issn pub-type="ppub">2049-9434</issn>
<issn pub-type="epub">2049-9442</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">BR-21-5-01856</article-id>
<article-id pub-id-type="doi">10.3892/br.2024.1856</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Behavioral video coding analysis of chronic morphine administration in rats</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Yin</surname><given-names>Jie</given-names></name>
<xref rid="af1-BR-21-5-01856" ref-type="aff">1</xref>
<xref rid="fn1-BR-21-5-01856" ref-type="author-notes">&#x002A;</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Zhang</surname><given-names>Tiecheng</given-names></name>
<xref rid="af2-BR-21-5-01856" ref-type="aff">2</xref>
<xref rid="fn1-BR-21-5-01856" ref-type="author-notes">&#x002A;</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Li</surname><given-names>Dan</given-names></name>
<xref rid="af3-BR-21-5-01856" ref-type="aff">3</xref>
<xref rid="fn1-BR-21-5-01856" ref-type="author-notes">&#x002A;</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Xu</surname><given-names>Fan</given-names></name>
<xref rid="af2-BR-21-5-01856" ref-type="aff">2</xref>
<xref rid="fn1-BR-21-5-01856" ref-type="author-notes">&#x002A;</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Li</surname><given-names>Huan</given-names></name>
<xref rid="af2-BR-21-5-01856" ref-type="aff">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Pan</surname><given-names>Xinyu</given-names></name>
<xref rid="af2-BR-21-5-01856" ref-type="aff">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Liu</surname><given-names>Fang</given-names></name>
<xref rid="af2-BR-21-5-01856" ref-type="aff">2</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Zhao</surname><given-names>Yongqi</given-names></name>
<xref rid="af1-BR-21-5-01856" ref-type="aff">1</xref>
<xref rid="c1-BR-21-5-01856" ref-type="corresp"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Weng</surname><given-names>Xiechuan</given-names></name>
<xref rid="af1-BR-21-5-01856" ref-type="aff">1</xref>
<xref rid="c1-BR-21-5-01856" ref-type="corresp"/>
</contrib>
</contrib-group>
<aff id="af1-BR-21-5-01856"><label>1</label>Department of Neuroscience, Beijing Institute of Basic Medical Sciences, Beijing 100850, P.R. China</aff>
<aff id="af2-BR-21-5-01856"><label>2</label>Department of Public Health, Chengdu Medical College, Sichuan 610500, P.R. China</aff>
<aff id="af3-BR-21-5-01856"><label>3</label>Jingnan Medical Area of the General Hospital of the People&#x0027;s Liberation Army, Beijing 100850, P.R. China</aff>
<author-notes>
<corresp id="c1-BR-21-5-01856"><italic>Correspondence to:</italic> Dr Xiechuan Weng or Dr Yongqi Zhao, Department of Neuroscience, Beijing Institute of Basic Medical Sciences, 27 Taiping Road, Beijing 100850, P.R. China <email>wengxc2000@163.com yqzhaoprc@sina.com </email></corresp>
<fn id="fn1-BR-21-5-01856"><p><sup>&#x002A;</sup>Contributed equally</p></fn>
</author-notes>
<pub-date pub-type="collection">
<month>11</month>
<year>2024</year></pub-date>
<pub-date pub-type="epub">
<day>12</day>
<month>09</month>
<year>2024</year></pub-date>
<volume>21</volume>
<issue>5</issue>
<elocation-id>168</elocation-id>
<history>
<date date-type="received">
<day>05</day>
<month>04</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>20</day>
<month>08</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright: &#x00A9; 2024 Yin et al.</copyright-statement>
<copyright-year>2024</copyright-year>
<license license-type="open-access">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">Creative Commons Attribution-NonCommercial-NoDerivs License</ext-link>, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.</license-p></license>
</permissions>
<abstract>
<p>The present study assessed the behavior of morphine-addicted rats using behavioral video coding technology, to evaluate effective methods for identifying morphine addiction. Rats were divided into a control group (n=15) and a morphine addiction group (n=15). The morphine addiction model was established with a 14-day increasing dose scheme, confirmed using a conditional place preference (CPP) experiment. After successful modeling, the rats&#x0027; behavior was recorded for 12 h, then coded and analyzed using Observer XT behavior analysis software. Compared with the control group, morphine-addicted rats showed increased heat pain tolerance time (P=0.039) and spent more time in the white box during the CPP experiment (P&#x003C;0.001). Video coding analysis revealed significant behavioral changes in morphine-addicted rats compared to controls. In addition to being lighter, morphine-addicted rats showed decreased water intake, reduced licking of forelimbs and hind limbs, and altered sleeping posture (sleeping curled up) during the day (all P&#x003C;0.05). In conclusion, chronic morphine administration in rats leads to distinctive behavioral changes, including decreased licking frequency, reduced water intake and altered sleep posture. Video coding analysis, as a safe and non-invasive method, may provide a convenient and efficient approach for studying morphine addiction in rats.</p>
</abstract>
<kwd-group>
<kwd>morphine</kwd>
<kwd>addiction</kwd>
<kwd>rat</kwd>
<kwd>conditional place preference experiment</kwd>
<kwd>video coding</kwd>
</kwd-group>
<funding-group>
<funding-statement><bold>Funding:</bold> This study was supported by the National Natural Science Foundation of China (grant no. 82073833) and the National Key R&#x0026;D Plan (grant nos. 2022YFC3600500 and 2022YFC3600502).</funding-statement>
</funding-group>
</article-meta>
</front>
<body>
<sec sec-type="intro">
<title>Introduction</title>
<p>Morphine, a typical opioid, is used in clinical settings to relieve cancer-related pain, especially in patients with bone cancer (<xref rid="b1-BR-21-5-01856 b2-BR-21-5-01856 b3-BR-21-5-01856 b4-BR-21-5-01856" ref-type="bibr">1-4</xref>). However, addiction and dependence remain significant issues that affect its clinical use (<xref rid="b5-BR-21-5-01856 b6-BR-21-5-01856 b7-BR-21-5-01856 b8-BR-21-5-01856" ref-type="bibr">5-8</xref>). In the context of social and public health, drug abuse and addiction are major public health concerns (<xref rid="b9-BR-21-5-01856 b10-BR-21-5-01856 b11-BR-21-5-01856 b12-BR-21-5-01856" ref-type="bibr">9-12</xref>). Addiction is currently viewed as a chronic and relapsing disorder (<xref rid="b13-BR-21-5-01856 b14-BR-21-5-01856 b15-BR-21-5-01856" ref-type="bibr">13-15</xref>). The process of drug addiction engages reward-related learning and memory systems, showing synaptic plasticity within these systems (<xref rid="b16-BR-21-5-01856 b17-BR-21-5-01856 b18-BR-21-5-01856 b19-BR-21-5-01856 b20-BR-21-5-01856 b21-BR-21-5-01856 b22-BR-21-5-01856 b23-BR-21-5-01856 b24-BR-21-5-01856 b25-BR-21-5-01856 b26-BR-21-5-01856 b27-BR-21-5-01856 b28-BR-21-5-01856" ref-type="bibr">16-28</xref>). The mechanisms behind opioid addiction are closely related to the central dopamine reward neural pathway, mainly involving the prefrontal cortex (<xref rid="b29-BR-21-5-01856" ref-type="bibr">29</xref>), the nucleus accumbens (<xref rid="b30-BR-21-5-01856 b31-BR-21-5-01856 b32-BR-21-5-01856" ref-type="bibr">30-32</xref>), and the ventral tegmental area (<xref rid="b33-BR-21-5-01856 b34-BR-21-5-01856 b35-BR-21-5-01856 b36-BR-21-5-01856 b37-BR-21-5-01856 b38-BR-21-5-01856" ref-type="bibr">33-38</xref>). Exploring the neurobiological mechanisms of drug addiction is crucial for clinical treatment.</p>
<p>Research on opioid addiction mechanisms often focuses on the morphine dependence model in rodents, usually rats or mice. The success of this model is assessed through conditioned place preference (CPP) or self-administration (SA) experiments (<xref rid="b39-BR-21-5-01856 b40-BR-21-5-01856 b41-BR-21-5-01856 b42-BR-21-5-01856 b43-BR-21-5-01856" ref-type="bibr">39-43</xref>). However, these methods are time-consuming, labor-intensive, require long-term behavioral training of animals and are subject to experimenter bias. CPP is an experimental tool for evaluating drug-seeking behavior or psychological craving in animals, requiring the association of a rewarding stimulus with a non-rewarding conditioned stimulus to confirm the presence of a rewarding stimulus. This process is tedious, time-consuming and requires a large sample size to avoid errors. SA experiments are the standard used for verifying drug addiction but need specific environments and equipment, and trained personnel. Additionally, issues such as hemorrhage, trauma, infection and death due to intravenous intubation in animals can affect the experimental results and process (<xref rid="b44-BR-21-5-01856" ref-type="bibr">44</xref>).</p>
<p>To the best of our knowledge, there have been no previous reports on the use of behavioral video coding analysis for morphine addiction. Behavioral video analysis technology may provide a convenient and efficient method for studying addictive behaviors. Recording videos of animals during the addiction modeling process and then coding these behaviors (<xref rid="b45-BR-21-5-01856" ref-type="bibr">45</xref>) allows for the identification of characteristic behavioral changes following morphine addiction in rats. Therefore, the present study assessed the behavior of morphine-addicted rats through behavioral video analysis and to evaluate this potentially efficient method to verify morphine addiction model in rats, offering a new approach for future studies on drug addiction behavior.</p>
</sec>
<sec sec-type="Materials|methods">
<title>Materials and methods</title>
<sec>
<title/>
<sec>
<title>Animals</title>
<p>Sprague-Dawley (SD) rats were purchased from SPF Biotechnology Co., Ltd. Rats were housed in a temperature-controlled environment (21-22&#x02DA;C) within an animal holding room, following a 12 h light/dark cycle. Food and tap water were available <italic>ad libitum</italic>. The morphology, behavior, diet and water intake of the rats were observed at 8:00 a.m. and 8:00 p.m. each day. The body weight of the rats was measured every day before morphine injection. The experiment lasted a total of 22 days. Rats were acclimated to the laboratory for 1 week (day -6 to day 0) before starting administration. Chronic morphine administration and CPP assessment were performed in rats from day 1 to day 14, with video recording of rat behavior was carried out on day 15. The ethics committee of Beijing Institute of Basic Medical Sciences (Beijing, China; approval no. IACUC-DWZX-2022-715) approved the experimental protocol.</p>
<p>The experiment would be terminated in the event of any serious harm to animal welfare (including but not limited to): i) Loss of 15-20&#x0025; of body weight; ii) infection in brain area; iii) other indicators such as pain, respiration (severe respiratory tract infection, dyspnea, cyanosis and other phenomena) and appearance (severe muscle atrophy and non-healing wounds). No rats met the criteria for early euthanasia during the course of the present study. After completing the experiment, the rats were placed into a non-precharged chamber and euthanized by CO<sub>2</sub> inhalation (30&#x0025; vol/min). Death was confirmed by cardiac and respiratory arrest and dilated pupils.</p>
<p><italic>Drugs:</italic> Morphine hydrochloride injection (10 mg/ml, Shenyang First Pharmaceutical Factory, Shenyang) was diluted with sterile saline to achieve a 2.5 mg/ml working solution.</p>
</sec>
<sec>
<title>Apparatus</title>
<p>A Hot and Cold Plate Plantar Analgesia Instrument (cat. no. 28-0010; Shenzhen Huayang Biotech Co., Ltd.) was used to assess the thermal pain response of rats. The device included a transparent plastic chamber (25 cm diameter, 60 cm height) and a heating plate. Rats were placed in the plastic chamber, and the heating plate temperature was kept at 40&#x00B1;1&#x02DA;C using a thermal probe and electronic feedback circuit. The timer started when the rats were placed in the chamber and was stopped manually when the rats showed behaviors such as lifting their hind limbs or licking their forelimbs. If no thermal response was observed within 3 min, the timer was stopped and the rats were promptly removed.</p>
<p>A Xiaomi Smart Video Camera PTZ Version 2K (cat. no. MJSXJ09CM; Xiaomi Inc.) was placed in the rat cage for video recording. A wooden board with a 5 cm diameter circular hole was positioned between the camera and the rat.</p>
<p>For the CPP experiment, a CPP apparatus was used, consisting of two compartments (30x60x30 cm; Zhongshi Technology). The different compartments had distinct floors and walls, separated by a removable plastic board. One compartment had black and white striped walls and a white floor, while the other had black and white checkered walls and a black floor. The test chamber was set up under 40 lux dim lighting and shielded from white noise (<xref rid="b46-BR-21-5-01856" ref-type="bibr">46</xref>).</p>
<p>The Observer XT (Noldus Information Technology BV) software was used for coding and analyzing recorded rat videos, focusing on typical rat behaviors (<xref rid="b45-BR-21-5-01856" ref-type="bibr">45</xref>).</p>
</sec>
<sec>
<title>Morphine administration</title>
<p>The morphine dependence model was established in 6-week-old (weight, 180-200 g) SD rats through a 14-day continuous dose escalation protocol. Male (n=15) and female (n=15) rats were randomly divided into two groups (<xref rid="b47-BR-21-5-01856 b48-BR-21-5-01856 b49-BR-21-5-01856 b50-BR-21-5-01856 b51-BR-21-5-01856 b52-BR-21-5-01856" ref-type="bibr">47-52</xref>). The morphine group received intraperitoneal morphine at a dose of 5 mg/kg on day 1, while the control group received an equivalent volume of normal saline. The morphine dose increased gradually, reaching 100 mg/kg on day 14 for the morphine-addicted rats, while the control rats continued to receive an equivalent volume of normal saline (<xref rid="b53-BR-21-5-01856 b54-BR-21-5-01856 b55-BR-21-5-01856 b56-BR-21-5-01856 b57-BR-21-5-01856" ref-type="bibr">53-57</xref>). The initial dose of morphine group was 5 mg/kg on the first day, and the dose gradient was 5 mg/kg per day from day 2 to day 7, 10 mg/kg per day from day 8 to day 14, and reached 100 mg/kg on day 14 (<xref rid="b53-BR-21-5-01856 b54-BR-21-5-01856 b55-BR-21-5-01856 b56-BR-21-5-01856 b57-BR-21-5-01856 b58-BR-21-5-01856 b59-BR-21-5-01856 b60-BR-21-5-01856 b61-BR-21-5-01856 b62-BR-21-5-01856 b63-BR-21-5-01856 b64-BR-21-5-01856 b65-BR-21-5-01856" ref-type="bibr">53-65</xref>). The half-life of morphine in rats is generally 3-4 h, the drug effect of morphine lasts for 4-6 h and morphine is largely metabolized in 8-10 h (<xref rid="b66-BR-21-5-01856 b67-BR-21-5-01856 b68-BR-21-5-01856 b69-BR-21-5-01856" ref-type="bibr">66-69</xref>). Morphine was administered daily at 8 am and 8 pm, ensuring an interval of about 12 h between doses (<xref rid="b70-BR-21-5-01856" ref-type="bibr">70</xref>).</p>
</sec>
<sec>
<title>Plantar heat tolerance test</title>
<p>Prior to each intraperitoneal injection of morphine, the time from the beginning of exposure to the hot plate at 40&#x02DA;C to the lifting or licking of the hind foot was measured. The maximum measurement time was limited to 3 min. The same measurement was taken 1.5 h after the intraperitoneal injection of morphine under the same conditions, recording the time to foot lifting or licking.</p>
</sec>
<sec>
<title>CPP Test</title>
<p>The CPP experiment was divided into two phases, the pre-experimental phase and the test phase (<xref rid="b46-BR-21-5-01856" ref-type="bibr">46</xref>). The pre-experimental phase lasted four consecutive days, with two sessions conducted daily. Rats (n=10) were randomly selected from each of the morphine and control groups, resulting in a total of 20 rats. Each session lasted 15 min. Conditioned reflexes were established by confining the rats to a white drug delivery box (referred to as the white box) for 15 min, during which they received injections of either morphine (with dosage according to the aforementioned protocol) for the morphine group or an equivalent volume of saline for the control group, administered intraperitoneally. On day 4, during the retention experiment, the rats were released from the central section of the CPP apparatus and allowed to freely explore the two chambers for 15 min.</p>
<p>In the final testing phase, the same procedure was repeated for four consecutive days. CPP training was performed twice a day for 15 min each for 3 days and the CPP test was performed on the fourth day. The rats were again confined to the white box for 15 min, receiving the corresponding injections (morphine for the morphine group, with the final dose reaching 100 mg/kg, and an equivalent volume of saline for the control group). On day 14, during the test experiment, the rats were released from the central part of the CPP apparatus and allowed to explore the two chambers for 15 min.</p>
</sec>
<sec>
<title>Video behavior coding</title>
<p>During the 14-day morphine addiction model, rats were randomly selected from each of the two experiment groups (n=8 per group), and placed in a cage with one rat per cage. On day 15, video recordings were made and subsequently coded and analyzed using Observer XT software to quantify behavioral differences between the two groups.</p>
<p>The observed rats were divided into two batches of 8 (each with 4 addicted rats and 4 control rats), with one batch observed per day. Video recordings were made from 8:00 a.m. to 8:00 p.m. each day, with one rat per cage. A Xiaomi cloud platform video camera was temporarily placed in each rat cage, isolated from the rats by a wooden board, this setup allowed continuous recording of the rats&#x0027; activity and behavior for 12 h, with the recorded video retained for subsequent analysis. Video coding and analysis were conducted using Observer XT software to examine differences in classical behaviors (such as eating, drinking, licking forelimbs, licking hind limbs, sleeping, walking and scratching) between the morphine group rats post-morphine addiction and the control group rats (<xref rid="b45-BR-21-5-01856" ref-type="bibr">45</xref>).</p>
</sec>
<sec>
<title>Statistical analysis</title>
<p>Data analysis was performed using GraphPad Prism (version 9; Dotmatics). The Wilcoxon rank-sum test and two-way ANOVA with Bonferroni correction were used to assess both experimental data and behavioral video coding recordings. P&#x003C;0.05 was considered to indicate a statistically significant difference. Data are presented as mean &#x00B1; SEM.</p>
</sec>
</sec>
</sec>
<sec sec-type="Results">
<title>Results</title>
<sec>
<title/>
<sec>
<title>Effect of continuous morphine administration on rat body weight</title>
<p>Following 14 days of escalating morphine doses, the weight difference between the morphine group and the control group showed a gradual and significant increase (day 14, z=2.717, P=0.0057, <xref rid="f1-BR-21-5-01856" ref-type="fig">Fig. 1</xref>). After 14 days, compared with the control group, the weight growth rate of morphine group rats was lower. The final average body weight on day 14 was 206.2&#x00B1;3.4 g (maximum individual body weight, 222.0 g) for the morphine group. In contrast, the body weight of rats in the control group showed a steady increase, with a stable growth rate. The final average body weight on day 14 for the control group was 233.6&#x00B1;8.0 g (maximum individual body weight, 287.7 g). A difference between body weight in the two groups was evident from the first day, which increased over time. On day 14, the average body weight of control rats exceeded that of morphine-rats by 27.4 g with the greatest body weight difference between the two groups being 70.3 g.</p>
</sec>
<sec>
<title>Effect of morphine injection on thermal pain tolerance in rats</title>
<p>At 1.5 h post-intraperitoneal morphine injection, the morphine group exhibited a significantly extended duration of thermal pain tolerance compared with the same group pre-injection. There was no significant difference in thermal pain tolerance following saline injection in the control group. Ultimately, morphine-addicted rats demonstrated longer thermal tolerance than control rats (U=74.4, P=0.039, <xref rid="f2-BR-21-5-01856" ref-type="fig">Fig. 2</xref>).</p>
</sec>
<sec>
<title>CPP experiments in morphine-addicted rats</title>
<p>CPP experiments were conducted on days 1-4 and days 11-14 for both the morphine and control groups. The analysis of CPP results involved recording the time spent by rats in the white box. The results before morphine addiction (day 4), demonstrated no statistically significant difference between the morphine and control groups (F=6.1., P=0.64, <xref rid="f3-BR-21-5-01856" ref-type="fig">Fig. 3</xref>), indicating equivalent white box time for both groups.</p>
<p>In the experiment after morphine addiction (day 14), a significant difference was demonstrated between the morphine and control groups regarding time spent in the white box (F=5.7, P&#x003C;0.001, <xref rid="f3-BR-21-5-01856" ref-type="fig">Fig. 3</xref>), which demonstrated that morphine administration increased the time spent in the white box compared to saline administration, which validated the rat addiction model. Additionally, there was a significant difference in the white box time of morphine group rats before and after addiction (F=11.5, P&#x003C;0.001, <xref rid="f3-BR-21-5-01856" ref-type="fig">Fig. 3</xref>), further verifying the success of the morphine addiction model in rats.</p>
</sec>
<sec>
<title>Video coding analysis of the effects of morphine dependence on rat behavior</title>
<p>To record and statistically analyze the characteristic behaviors of rats after addiction, a 12-h video of rats in the morphine group and rats in the control group was recorded. The video was then coded and analyzed using Observer XT software, and the data was exported for analysis using the Mann-Whitney test to compare the statistical differences in the behaviors of the two groups. Compared with the control rats, the morphine group rats showed significant differences in drinking and licking the fore and hind limbs. They also exhibited characteristic behaviors such as an increased number ball sleeping, increased scratching, increased fur licking and changes in walking time at specific times of the day.</p>
<p>Regarding feeding, rats in the morphine group did not show significant differences compared with control rats (U=65.5, P=0.98, <xref rid="f4-BR-21-5-01856" ref-type="fig">Fig. 4A</xref>). However, in terms of drinking, the morphine group drank significantly less water than the control group (U=17, P=0.0014, <xref rid="f4-BR-21-5-01856" ref-type="fig">Fig. 4B</xref>). For the licking of the forelimbs, the morphine group licked significantly less compared with the control group (U=27, P=0.014, <xref rid="f4-BR-21-5-01856" ref-type="fig">Fig. 4C</xref>). In contrast, for the licking of the hindlimbs, the morphine group licked significantly less than the control group (U=32, P=0.035, <xref rid="f4-BR-21-5-01856" ref-type="fig">Fig. 4D</xref>). There was no significant difference between the two groups in terms of lifting the hindlimbs (U=62, P=0.082&#x003E;0.05, <xref rid="f4-BR-21-5-01856" ref-type="fig">Fig. 4E</xref>).</p>
<p>In the present study, &#x2018;marten sleeping&#x2019; means sleeping curled up in the lateral arch of the rat with a clear view of the entire head. &#x2018;Ball sleeping&#x2019; is when the rat is resting with its head curled up on its abdomen and its eyes closed. In the 12-h observation period, morphine-addicted rats displayed significantly more &#x2018;ball sleeping&#x2019; behavior compared with control rats during the 2:30-3:00 p.m. period (z=-2.412, P=0.0159, <xref rid="f5-BR-21-5-01856" ref-type="fig">Fig. 5A</xref>). There was no significant difference between the groups for &#x2018;marten sleeping&#x2019; at any recorded time period. The frequency of scratching showed a statistically significant difference only during the 1:00-1:30 p.m. period (z=-1.964, P=0.0495; <xref rid="f5-BR-21-5-01856" ref-type="fig">Fig. 5C</xref>). The frequency of licking showed a significant difference between the groups during the 3:30-4:00 p.m. period (z=-2.29, P=0.022, <xref rid="f5-BR-21-5-01856" ref-type="fig">Fig. 5D</xref>). Additionally, the morphine group walked significantly less than the control group during the 12:00 a.m.-12:30 p.m. and 6:00-6:30 p.m. periods (z=-2.093, P=0.036; z=-2.039, P=0.0415; <xref rid="f5-BR-21-5-01856" ref-type="fig">Fig. 5E</xref>). These results indicate that rats chronically injected with morphine exhibit characteristic behaviors such as increased ball sleeping, increased scratching, increased hair licking, and changes in walking behaviorat specific times of the day.</p>
</sec>
</sec>
</sec>
<sec sec-type="Discussion">
<title>Discussion</title>
<p>Morphine addiction and dependence are recognized as neuropsychiatric diseases, involving various behavioral, neurobiological and molecular changes (<xref rid="b55-BR-21-5-01856" ref-type="bibr">55</xref>,<xref rid="b71-BR-21-5-01856 b72-BR-21-5-01856 b73-BR-21-5-01856 b74-BR-21-5-01856 b75-BR-21-5-01856" ref-type="bibr">71-75</xref>). In animal models, especially in rats, studying behavioral manifestations after morphine addiction is crucial for understanding the neural mechanisms of addiction and finding treatments. Video coding and analysis technology record animal behavior under specific conditions, using computer software to encode, identify and analyze the behavioral data. This technology enables comprehensive recording and accurate analysis of animal behavior, which is safe and non-invasive, and does not interfere with the animals&#x0027; activities. Thus, it reveals the behavioral characteristics of rats after morphine addiction more accurately than traditional behavioral observation.</p>
<p>At present, the mechanism of morphine addiction has been studied and evaluated using various animal models, among which the rat model of chronic morphine administration is commonly used (<xref rid="b48-BR-21-5-01856" ref-type="bibr">48</xref>,<xref rid="b49-BR-21-5-01856" ref-type="bibr">49</xref>,<xref rid="b51-BR-21-5-01856" ref-type="bibr">51</xref>,<xref rid="b76-BR-21-5-01856" ref-type="bibr">76</xref>). In studies of rat or mouse behavior, most analyses use experiments to verify behavior, such as the rotarod, open field test, elevated plus maze test, cliff hanging, passive avoidance test, Morris water maze, light/dark box or light spot tests. The study of daily behaviors in rats mainly focuses on neuropathic pain and other diseases, using video coding analysis for assessment of daily walking gait (<xref rid="b77-BR-21-5-01856 b78-BR-21-5-01856 b79-BR-21-5-01856 b80-BR-21-5-01856 b81-BR-21-5-01856" ref-type="bibr">77-81</xref>). Research on addictive behavior primarily involves self-administration and CPP tests, with little use of daily behavior video coding analysis (<xref rid="b82-BR-21-5-01856" ref-type="bibr">82</xref>,<xref rid="b83-BR-21-5-01856" ref-type="bibr">83</xref>). However, after morphine administration, whether rats are addicted or not is usually judged by CPP test and self-administration experiment, and these methods have certain limitations and shortcomings, such as time-consuming, labor-intensive, requiring long-term behavioral training of animals and risk of infection and death due to invasive procedures. Therefore, in the present study, video coding was used to analyze the characteristic behavior of chronic morphine administration in rats, which was expected to provide a simple and quick method to analyze and evaluate morphine addiction through the behavioral changes before and after morphine addiction. Video behavior observation and analysis has many applications in studying animal behaviors such as pain, depression and anxiety. For example, Braw <italic>et al</italic> (<xref rid="b84-BR-21-5-01856" ref-type="bibr">84</xref>) demonstrated the depression and anxiety behavior of rats with different genetic models, finding differential expression of anxiety in pre-pubertal rats belonging to the &#x2018;depressed&#x2019; strains, suggesting that these strains may be suitable for modelling different sub-groups of depression at young ages. Medvedev <italic>et al</italic> (<xref rid="b85-BR-21-5-01856" ref-type="bibr">85</xref>) demonstrated MK-801 and memantine acted against tactile allodynia induced by sciatic nerve ligatio. Yuan and Devine (<xref rid="b86-BR-21-5-01856" ref-type="bibr">86</xref>) demonstrated the self-injury behavior of rats induced by anxiety drugs, and finding the rats given anxiety-inducing drugs showed stronger self-injurious behavior. To the best of our knowledge, no previous studies have performed video behavioral coding analysis of morphine addiction behavior in rats. Therefore, using video coding analysis to study addiction behavior characteristics introduces innovative changes and has potential value for the researching of addiction mechanisms and treatments.</p>
<p>In the present study, weight observation, heat tolerance test, CPP test and behavioral video coding analysis were performed using a morphine addiction model in rats. The results indicated that morphine-addicted rats had increased heat pain tolerance and reduced weight gain. The present study used the method of video behavior coding analysis for the first time to find that rats with chronic morphine administration exhibited slower weight gain, smaller body size, and fragile fur (<xref rid="b87-BR-21-5-01856" ref-type="bibr">87</xref>). Behavioral changes were mainly characterized by decreased water intake, decreased toe licking and increased daytime sleep in a spherical posture. The present study analyzed various behavioral changes in rats before and after morphine addiction and provided a new method for verifying the morphine addiction rat model through behavioral video analysis (<xref rid="b46-BR-21-5-01856 b47-BR-21-5-01856 b48-BR-21-5-01856 b49-BR-21-5-01856" ref-type="bibr">46-49</xref>,<xref rid="b51-BR-21-5-01856" ref-type="bibr">51</xref>,<xref rid="b52-BR-21-5-01856" ref-type="bibr">52</xref>).</p>
<p>Behavioral video analysis of morphine-addicted rats revealed significant differences in drinking and licking of the fore and hind limbs, as well as in sleeping postures and scratching during the middle of the day. According to Kon <italic>et al</italic> (<xref rid="b88-BR-21-5-01856" ref-type="bibr">88</xref>), morphine increases the expression of aquaporin-3 water channels in the colon by increasing the secretion of serotonin, which enhances water absorption from the lumen to the vasculature of the colon. Deroche <italic>et al</italic> (<xref rid="b89-BR-21-5-01856" ref-type="bibr">89</xref>) reported that opioids bind to MOP receptors in enteric neurons, delaying gastrointestinal transit time, and stimulating non-propulsive GI motility and the pylorus and ileocecal sphincters. Consequently, chronic morphine administration results in diminished thirst and reduced water excretion, leading to decreased water intake. Morphine group rats exhibited more frequent ball sleeping, especially during the 2:00-2:30 p.m. timeframe. The altered sleep posture suggests that long-term morphine exposure may lead to functional or structural changes in the limbic system and motor cortex, which are involved in mediating instinctive and emotional behaviors through Papez circuits (<xref rid="b90-BR-21-5-01856" ref-type="bibr">90</xref>). It is speculated that morphine affects the neurons and neural circuits in the limbic system or cortical nuclei, resulting in changes in sleep posture.</p>
<p>The present study analyzed the behavioral characteristics of morphine-addicted rats using the minimum sample size necessary to achieve statistical significance. Increasing the sample size could provide more precise behavior analysis and more convincing experimental conclusions. Additionally, the 14-day morphine addiction model is currently complex; future optimizations could make the model more efficient and reduce animal suffering.</p>
<p>In summary, high-resolution video equipment was used to record the behavior of morphine-addicted rats, and behavioral video coding and identification analysis were performed to systematically study the characteristics of morphine addiction behavior. By analyzing the behavioral characteristics of morphine-addicted rats, we can better understand the occurrence and development of addiction, reveal the impact of addiction on rat behavior and its potential neural mechanisms, and provide important theoretical and methodological support for further research on the neural circuit mechanisms of addiction and the development of related treatment strategies.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgements</title>
<p>Not applicable.</p>
</ack>
<sec sec-type="data-availability">
<title>Availability of data and materials</title>
<p>The datasets used and/or analyzed during the study are available from the corresponding author upon reasonable request.</p>
</sec>
<sec>
<title>Authors&#x0027; contributions</title>
<p>JY performed multiple experiments, acquired data and wrote the first draft of the manuscript. JY, TZ, DL, HL, XP, and FL performed data analysis. YZ, FX, and XW contributed to the study design and participated in revising the manuscript. YZ, FX, and XW confirmed the authenticity of all raw data and all authors agreed to be accountable for all aspects of the study. All authors have read and approved the final manuscript.</p>
</sec>
<sec>
<title>Ethics approval and consent to participate</title>
<p>Experiments were conducted in compliance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals. The experimental procedures were approved by the ethics committee of Beijing Institute of Basic Medical Sciences (approval no. IACUC-DWZX-2022-715; Beijing, China).</p>
</sec>
<sec>
<title>Patient consent for publication</title>
<p>Not applicable.</p>
</sec>
<sec sec-type="COI-statement">
<title>Competing interests</title>
<p>The authors declare that they have no competing interests.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="b1-BR-21-5-01856"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>H&#x00E4;user</surname><given-names>W</given-names></name><name><surname>Welsch</surname><given-names>P</given-names></name><name><surname>Radbruch</surname><given-names>L</given-names></name><name><surname>Fisher</surname><given-names>E</given-names></name><name><surname>Bell</surname><given-names>RF</given-names></name><name><surname>Moore</surname><given-names>RA</given-names></name></person-group><article-title>Cannabis-based medicines and medical cannabis for adults with cancer pain</article-title><source>Cochrane Database Syst Rev</source><volume>6</volume><issue>Cd014915</issue><year>2023</year><pub-id pub-id-type="pmid">37283486</pub-id><pub-id pub-id-type="doi">10.1002/14651858.CD014915.pub2</pub-id></element-citation></ref>
<ref id="b2-BR-21-5-01856"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luger</surname><given-names>NM</given-names></name><name><surname>Mach</surname><given-names>DB</given-names></name><name><surname>Sevcik</surname><given-names>MA</given-names></name><name><surname>Mantyh</surname><given-names>PW</given-names></name></person-group><article-title>Bone cancer pain: From model to mechanism to therapy</article-title><source>J Pain Symptom Manage</source><volume>29 (5 Suppl)</volume><fpage>S32</fpage><lpage>S46</lpage><year>2005</year><pub-id pub-id-type="pmid">15907645</pub-id><pub-id pub-id-type="doi">10.1016/j.jpainsymman.2005.01.008</pub-id></element-citation></ref>
<ref id="b3-BR-21-5-01856"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mercadante</surname><given-names>S</given-names></name></person-group><article-title>Intravenous morphine for management of cancer pain</article-title><source>Lancet Oncol</source><volume>11</volume><fpage>484</fpage><lpage>489</lpage><year>2010</year><pub-id pub-id-type="pmid">20434717</pub-id><pub-id pub-id-type="doi">10.1016/S1470-2045(09)70350-X</pub-id></element-citation></ref>
<ref id="b4-BR-21-5-01856"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname><given-names>QN</given-names></name><name><surname>Chun</surname><given-names>SG</given-names></name><name><surname>Chow</surname><given-names>E</given-names></name><name><surname>Komaki</surname><given-names>R</given-names></name><name><surname>Liao</surname><given-names>Z</given-names></name><name><surname>Zacharia</surname><given-names>R</given-names></name><name><surname>Szeto</surname><given-names>BK</given-names></name><name><surname>Welsh</surname><given-names>JW</given-names></name><name><surname>Hahn</surname><given-names>SM</given-names></name><name><surname>Fuller</surname><given-names>CD</given-names></name><etal/></person-group><article-title>Single-Fraction stereotactic vs conventional multifraction radiotherapy for pain relief in patients with predominantly nonspine bone metastases: A Randomized phase 2 trial</article-title><source>JAMA Oncol</source><volume>5</volume><fpage>872</fpage><lpage>878</lpage><year>2019</year><pub-id pub-id-type="pmid">31021390</pub-id><pub-id pub-id-type="doi">10.1001/jamaoncol.2019.0192</pub-id></element-citation></ref>
<ref id="b5-BR-21-5-01856"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mantsch</surname><given-names>JR</given-names></name><name><surname>Baker</surname><given-names>DA</given-names></name><name><surname>Funk</surname><given-names>D</given-names></name><name><surname>L&#x00EA;</surname><given-names>AD</given-names></name><name><surname>Shaham</surname><given-names>Y</given-names></name></person-group><article-title>Stress-Induced reinstatement of drug seeking: 20 years of progress</article-title><source>Neuropsychopharmacology</source><volume>41</volume><fpage>335</fpage><lpage>356</lpage><year>2016</year><pub-id pub-id-type="pmid">25976297</pub-id><pub-id pub-id-type="doi">10.1038/npp.2015.142</pub-id></element-citation></ref>
<ref id="b6-BR-21-5-01856"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reiner</surname><given-names>DJ</given-names></name><name><surname>Fredriksson</surname><given-names>I</given-names></name><name><surname>Lofaro</surname><given-names>OM</given-names></name><name><surname>Bossert</surname><given-names>JM</given-names></name><name><surname>Shaham</surname><given-names>Y</given-names></name></person-group><article-title>Relapse to opioid seeking in rat models: Behavior, pharmacology and circuits</article-title><source>Neuropsychopharmacology</source><volume>44</volume><fpage>465</fpage><lpage>477</lpage><year>2019</year><pub-id pub-id-type="pmid">30293087</pub-id><pub-id pub-id-type="doi">10.1038/s41386-018-0234-2</pub-id></element-citation></ref>
<ref id="b7-BR-21-5-01856"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shalev</surname><given-names>U</given-names></name><name><surname>Grimm</surname><given-names>JW</given-names></name><name><surname>Shaham</surname><given-names>Y</given-names></name></person-group><article-title>Neurobiology of relapse to heroin and cocaine seeking: A review</article-title><source>Pharmacol Rev</source><volume>54</volume><fpage>1</fpage><lpage>42</lpage><year>2002</year><pub-id pub-id-type="pmid">11870259</pub-id><pub-id pub-id-type="doi">10.1124/pr.54.1.1</pub-id></element-citation></ref>
<ref id="b8-BR-21-5-01856"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trujillo</surname><given-names>KA</given-names></name><name><surname>Akil</surname><given-names>H</given-names></name></person-group><article-title>Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801</article-title><source>Science</source><volume>251</volume><fpage>85</fpage><lpage>87</lpage><year>1991</year><pub-id pub-id-type="pmid">1824728</pub-id><pub-id pub-id-type="doi">10.1126/science.1824728</pub-id></element-citation></ref>
<ref id="b9-BR-21-5-01856"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garofoli</surname><given-names>M</given-names></name></person-group><article-title>Adolescent Substance Abuse</article-title><source>Prim Care</source><volume>47</volume><fpage>383</fpage><lpage>394</lpage><year>2020</year><pub-id pub-id-type="pmid">32423721</pub-id><pub-id pub-id-type="doi">10.1016/j.pop.2020.02.013</pub-id></element-citation></ref>
<ref id="b10-BR-21-5-01856"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname><given-names>DC</given-names></name></person-group><article-title>Drug overdose, addiction and binge drinking: Medical problems with public health consequences</article-title><source>R I Med J (2013)</source><volume>97</volume><fpage>18</fpage><lpage>19</lpage><year>2014</year><pub-id pub-id-type="pmid">25271654</pub-id></element-citation></ref>
<ref id="b11-BR-21-5-01856"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCarty</surname><given-names>D</given-names></name><name><surname>Argeriou</surname><given-names>M</given-names></name><name><surname>Huebner</surname><given-names>RB</given-names></name><name><surname>Lubran</surname><given-names>B</given-names></name></person-group><article-title>Alcoholism, drug abuse, and the homeless</article-title><source>Am Psychol</source><volume>46</volume><fpage>1139</fpage><lpage>1148</lpage><year>1991</year><pub-id pub-id-type="pmid">1772151</pub-id><pub-id pub-id-type="doi">10.1037//0003-066x.46.11.1139</pub-id></element-citation></ref>
<ref id="b12-BR-21-5-01856"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name></person-group><article-title>Drug addiction in China</article-title><source>Ann N Y Acad Sci</source><volume>1141</volume><fpage>304</fpage><lpage>317</lpage><year>2008</year><pub-id pub-id-type="pmid">18991965</pub-id><pub-id pub-id-type="doi">10.1196/annals.1441.025</pub-id></element-citation></ref>
<ref id="b13-BR-21-5-01856"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leshner</surname><given-names>AI</given-names></name></person-group><article-title>Addiction is a brain disease, and it matters</article-title><source>Science</source><volume>278</volume><fpage>45</fpage><lpage>47</lpage><year>1997</year><pub-id pub-id-type="pmid">9311924</pub-id><pub-id pub-id-type="doi">10.1126/science.278.5335.45</pub-id></element-citation></ref>
<ref id="b14-BR-21-5-01856"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>JF</given-names></name><name><surname>Li</surname><given-names>JX</given-names></name></person-group><article-title>Drug addiction: A curable mental disorder?</article-title><source>Acta Pharmacol Sin</source><volume>39</volume><fpage>1823</fpage><lpage>1829</lpage><year>2018</year><pub-id pub-id-type="pmid">30382181</pub-id><pub-id pub-id-type="doi">10.1038/s41401-018-0180-x</pub-id></element-citation></ref>
<ref id="b15-BR-21-5-01856"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nestler</surname><given-names>EJ</given-names></name></person-group><article-title>Molecular basis of long-term plasticity underlying addiction</article-title><source>Nat Rev Neurosci</source><volume>2</volume><fpage>119</fpage><lpage>128</lpage><year>2001</year><pub-id pub-id-type="pmid">11252991</pub-id><pub-id pub-id-type="doi">10.1038/35053570</pub-id></element-citation></ref>
<ref id="b16-BR-21-5-01856"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiamulera</surname><given-names>C</given-names></name><name><surname>Piva</surname><given-names>A</given-names></name><name><surname>Abraham</surname><given-names>WC</given-names></name></person-group><article-title>Glutamate receptors and metaplasticity in addiction</article-title><source>Curr Opin Pharmacol</source><volume>56</volume><fpage>39</fpage><lpage>45</lpage><year>2021</year><pub-id pub-id-type="pmid">33128937</pub-id><pub-id pub-id-type="doi">10.1016/j.coph.2020.09.005</pub-id></element-citation></ref>
<ref id="b17-BR-21-5-01856"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fourgeaud</surname><given-names>L</given-names></name><name><surname>Mato</surname><given-names>S</given-names></name><name><surname>Bouchet</surname><given-names>D</given-names></name><name><surname>H&#x00E9;mar</surname><given-names>A</given-names></name><name><surname>Worley</surname><given-names>PF</given-names></name><name><surname>Manzoni</surname><given-names>OJ</given-names></name></person-group><article-title>A single in vivo exposure to cocaine abolishes endocannabinoid-mediated long-term depression in the nucleus accumbens</article-title><source>J Neurosci</source><volume>24</volume><fpage>6939</fpage><lpage>6945</lpage><year>2004</year><pub-id pub-id-type="pmid">15295029</pub-id><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0671-04.2004</pub-id></element-citation></ref>
<ref id="b18-BR-21-5-01856"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gipson</surname><given-names>CD</given-names></name><name><surname>Kupchik</surname><given-names>YM</given-names></name><name><surname>Kalivas</surname><given-names>PW</given-names></name></person-group><article-title>Rapid, transient synaptic plasticity in addiction</article-title><source>Neuropharmacology</source><volume>76 Pt B</volume><fpage>276</fpage><lpage>286</lpage><year>2014</year><pub-id pub-id-type="pmid">23639436</pub-id><pub-id pub-id-type="doi">10.1016/j.neuropharm.2013.04.032</pub-id></element-citation></ref>
<ref id="b19-BR-21-5-01856"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hafenbreidel</surname><given-names>M</given-names></name><name><surname>Rafa Todd</surname><given-names>C</given-names></name><name><surname>Mueller</surname><given-names>D</given-names></name></person-group><article-title>Infralimbic GluN2A-Containing NMDA receptors modulate reconsolidation of cocaine self-administration memory</article-title><source>Neuropsychopharmacology</source><volume>42</volume><fpage>1113</fpage><lpage>1125</lpage><year>2017</year><pub-id pub-id-type="pmid">28042872</pub-id><pub-id pub-id-type="doi">10.1038/npp.2016.288</pub-id></element-citation></ref>
<ref id="b20-BR-21-5-01856"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hyman</surname><given-names>SE</given-names></name></person-group><article-title>Addiction: A disease of learning and memory</article-title><source>Am J Psychiatry</source><volume>162</volume><fpage>1414</fpage><lpage>1422</lpage><year>2005</year><pub-id pub-id-type="pmid">16055762</pub-id><pub-id pub-id-type="doi">10.1176/appi.ajp.162.8.1414</pub-id></element-citation></ref>
<ref id="b21-BR-21-5-01856"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kauer</surname><given-names>JA</given-names></name><name><surname>Malenka</surname><given-names>RC</given-names></name></person-group><article-title>Synaptic plasticity and addiction</article-title><source>Nat Rev Neurosci</source><volume>8</volume><fpage>844</fpage><lpage>858</lpage><year>2007</year><pub-id pub-id-type="pmid">17948030</pub-id><pub-id pub-id-type="doi">10.1038/nrn2234</pub-id></element-citation></ref>
<ref id="b22-BR-21-5-01856"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keralapurath</surname><given-names>MM</given-names></name><name><surname>Briggs</surname><given-names>SB</given-names></name><name><surname>Wagner</surname><given-names>JJ</given-names></name></person-group><article-title>Cocaine self-administration induces changes in synaptic transmission and plasticity in ventral hippocampus</article-title><source>Addict Biol</source><volume>22</volume><fpage>446</fpage><lpage>456</lpage><year>2017</year><pub-id pub-id-type="pmid">26692207</pub-id><pub-id pub-id-type="doi">10.1111/adb.12345</pub-id></element-citation></ref>
<ref id="b23-BR-21-5-01856"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>L&#x00FC;scher</surname><given-names>C</given-names></name><name><surname>Malenka</surname><given-names>RC</given-names></name></person-group><article-title>Drug-evoked synaptic plasticity in addiction: From molecular changes to circuit remodeling</article-title><source>Neuron</source><volume>69</volume><fpage>650</fpage><lpage>663</lpage><year>2011</year><pub-id pub-id-type="pmid">21338877</pub-id><pub-id pub-id-type="doi">10.1016/j.neuron.2011.01.017</pub-id></element-citation></ref>
<ref id="b24-BR-21-5-01856"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mameli</surname><given-names>M</given-names></name><name><surname>Bellone</surname><given-names>C</given-names></name><name><surname>Brown</surname><given-names>MT</given-names></name><name><surname>L&#x00FC;scher</surname><given-names>C</given-names></name></person-group><article-title>Cocaine inverts rules for synaptic plasticity of glutamate transmission in the ventral tegmental area</article-title><source>Nat Neurosci</source><volume>14</volume><fpage>414</fpage><lpage>416</lpage><year>2011</year><pub-id pub-id-type="pmid">21336270</pub-id><pub-id pub-id-type="doi">10.1038/nn.2763</pub-id></element-citation></ref>
<ref id="b25-BR-21-5-01856"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tronson</surname><given-names>NC</given-names></name><name><surname>Taylor</surname><given-names>JR</given-names></name></person-group><article-title>Molecular mechanisms of memory reconsolidation</article-title><source>Nat Rev Neurosci</source><volume>8</volume><fpage>262</fpage><lpage>275</lpage><year>2007</year><pub-id pub-id-type="pmid">17342174</pub-id><pub-id pub-id-type="doi">10.1038/nrn2090</pub-id></element-citation></ref>
<ref id="b26-BR-21-5-01856"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tzschentke</surname><given-names>TM</given-names></name><name><surname>Schmidt</surname><given-names>WJ</given-names></name></person-group><article-title>Glutamatergic mechanisms in addiction</article-title><source>Mol Psychiatry</source><volume>8</volume><fpage>373</fpage><lpage>382</lpage><year>2003</year><pub-id pub-id-type="pmid">12740594</pub-id><pub-id pub-id-type="doi">10.1038/sj.mp.4001269</pub-id></element-citation></ref>
<ref id="b27-BR-21-5-01856"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Huijstee</surname><given-names>AN</given-names></name><name><surname>Mansvelder</surname><given-names>HD</given-names></name></person-group><article-title>Glutamatergic synaptic plasticity in the mesocorticolimbic system in addiction</article-title><source>Front Cell Neurosci</source><volume>8</volume><issue>466</issue><year>2014</year><pub-id pub-id-type="pmid">25653591</pub-id><pub-id pub-id-type="doi">10.3389/fncel.2014.00466</pub-id></element-citation></ref>
<ref id="b28-BR-21-5-01856"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ossipov</surname><given-names>MH</given-names></name><name><surname>Lai</surname><given-names>J</given-names></name><name><surname>King</surname><given-names>T</given-names></name><name><surname>Vanderah</surname><given-names>TW</given-names></name><name><surname>Malan</surname><given-names>TP Jr</given-names></name><name><surname>Hruby</surname><given-names>VJ</given-names></name><name><surname>Porreca</surname><given-names>F</given-names></name></person-group><article-title>Antinociceptive and nociceptive actions of opioids</article-title><source>J Neurobiol</source><volume>61</volume><fpage>126</fpage><lpage>148</lpage><year>2004</year><pub-id pub-id-type="pmid">15362157</pub-id><pub-id pub-id-type="doi">10.1002/neu.20091</pub-id></element-citation></ref>
<ref id="b29-BR-21-5-01856"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mickiewicz</surname><given-names>AL</given-names></name><name><surname>Napier</surname><given-names>TC</given-names></name></person-group><article-title>Repeated exposure to morphine alters surface expression of AMPA receptors in the rat medial prefrontal cortex</article-title><source>Eur J Neurosci</source><volume>33</volume><fpage>259</fpage><lpage>265</lpage><year>2011</year><pub-id pub-id-type="pmid">21175880</pub-id><pub-id pub-id-type="doi">10.1111/j.1460-9568.2010.07502.x</pub-id></element-citation></ref>
<ref id="b30-BR-21-5-01856"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boudreau</surname><given-names>AC</given-names></name><name><surname>Wolf</surname><given-names>ME</given-names></name></person-group><article-title>Behavioral sensitization to cocaine is associated with increased AMPA receptor surface expression in the nucleus accumbens</article-title><source>J Neurosci</source><volume>25</volume><fpage>9144</fpage><lpage>9151</lpage><year>2005</year><pub-id pub-id-type="pmid">16207873</pub-id><pub-id pub-id-type="doi">10.1523/JNEUROSCI.2252-05.2005</pub-id></element-citation></ref>
<ref id="b31-BR-21-5-01856"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hemby</surname><given-names>SE</given-names></name><name><surname>Tang</surname><given-names>W</given-names></name><name><surname>Muly</surname><given-names>EC</given-names></name><name><surname>Kuhar</surname><given-names>MJ</given-names></name><name><surname>Howell</surname><given-names>L</given-names></name><name><surname>Mash</surname><given-names>DC</given-names></name></person-group><article-title>Cocaine-induced alterations in nucleus accumbens ionotropic glutamate receptor subunits in human and non-human primates</article-title><source>J Neurochem</source><volume>95</volume><fpage>1785</fpage><lpage>1793</lpage><year>2005</year><pub-id pub-id-type="pmid">16363995</pub-id><pub-id pub-id-type="doi">10.1111/j.1471-4159.2005.03517.x</pub-id></element-citation></ref>
<ref id="b32-BR-21-5-01856"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sutton</surname><given-names>MA</given-names></name><name><surname>Schmidt</surname><given-names>EF</given-names></name><name><surname>Choi</surname><given-names>KH</given-names></name><name><surname>Schad</surname><given-names>CA</given-names></name><name><surname>Whisler</surname><given-names>K</given-names></name><name><surname>Simmons</surname><given-names>D</given-names></name><name><surname>Karanian</surname><given-names>DA</given-names></name><name><surname>Monteggia</surname><given-names>LM</given-names></name><name><surname>Neve</surname><given-names>RL</given-names></name><name><surname>Self</surname><given-names>DW</given-names></name></person-group><article-title>Extinction-induced upregulation in AMPA receptors reduces cocaine-seeking behaviour</article-title><source>Nature</source><volume>421</volume><fpage>70</fpage><lpage>75</lpage><year>2003</year><pub-id pub-id-type="pmid">12511956</pub-id><pub-id pub-id-type="doi">10.1038/nature01249</pub-id></element-citation></ref>
<ref id="b33-BR-21-5-01856"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bachtell</surname><given-names>RK</given-names></name><name><surname>Choi</surname><given-names>KH</given-names></name><name><surname>Simmons</surname><given-names>DL</given-names></name><name><surname>Falcon</surname><given-names>E</given-names></name><name><surname>Monteggia</surname><given-names>LM</given-names></name><name><surname>Neve</surname><given-names>RL</given-names></name><name><surname>Self</surname><given-names>DW</given-names></name></person-group><article-title>Role of GluR1 expression in nucleus accumbens neurons in cocaine sensitization and cocaine-seeking behavior</article-title><source>Eur J Neurosci</source><volume>27</volume><fpage>2229</fpage><lpage>2240</lpage><year>2008</year><pub-id pub-id-type="pmid">18430032</pub-id><pub-id pub-id-type="doi">10.1111/j.1460-9568.2008.06199.x</pub-id></element-citation></ref>
<ref id="b34-BR-21-5-01856"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Conrad</surname><given-names>KL</given-names></name><name><surname>Tseng</surname><given-names>KY</given-names></name><name><surname>Uejima</surname><given-names>JL</given-names></name><name><surname>Reimers</surname><given-names>JM</given-names></name><name><surname>Heng</surname><given-names>LJ</given-names></name><name><surname>Shaham</surname><given-names>Y</given-names></name><name><surname>Marinelli</surname><given-names>M</given-names></name><name><surname>Wolf</surname><given-names>ME</given-names></name></person-group><article-title>Formation of accumbens GluR2-lacking AMPA receptors mediates incubation of cocaine craving</article-title><source>Nature</source><volume>454</volume><fpage>118</fpage><lpage>121</lpage><year>2008</year><pub-id pub-id-type="pmid">18500330</pub-id><pub-id pub-id-type="doi">10.1038/nature06995</pub-id></element-citation></ref>
<ref id="b35-BR-21-5-01856"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kasanetz</surname><given-names>F</given-names></name><name><surname>Deroche-Gamonet</surname><given-names>V</given-names></name><name><surname>Berson</surname><given-names>N</given-names></name><name><surname>Balado</surname><given-names>E</given-names></name><name><surname>Lafourcade</surname><given-names>M</given-names></name><name><surname>Manzoni</surname><given-names>O</given-names></name><name><surname>Piazza</surname><given-names>PV</given-names></name></person-group><article-title>Transition to addiction is associated with a persistent impairment in synaptic plasticity</article-title><source>Science</source><volume>328</volume><fpage>1709</fpage><lpage>1712</lpage><year>2010</year><pub-id pub-id-type="pmid">20576893</pub-id><pub-id pub-id-type="doi">10.1126/science.1187801</pub-id></element-citation></ref>
<ref id="b36-BR-21-5-01856"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>LaLumiere</surname><given-names>RT</given-names></name><name><surname>Kalivas</surname><given-names>PW</given-names></name></person-group><article-title>Glutamate release in the nucleus accumbens core is necessary for heroin seeking</article-title><source>J Neurosci</source><volume>28</volume><fpage>3170</fpage><lpage>3177</lpage><year>2008</year><pub-id pub-id-type="pmid">18354020</pub-id><pub-id pub-id-type="doi">10.1523/JNEUROSCI.5129-07.2008</pub-id></element-citation></ref>
<ref id="b37-BR-21-5-01856"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Degoulet</surname><given-names>M</given-names></name><name><surname>Stelly</surname><given-names>CE</given-names></name><name><surname>Ahn</surname><given-names>KC</given-names></name><name><surname>Morikawa</surname><given-names>H</given-names></name></person-group><article-title>L-type Ca&#x00B2;<sup>+</sup> channel blockade with antihypertensive medication disrupts VTA synaptic plasticity and drug-associated contextual memory</article-title><source>Mol Psychiatry</source><volume>21</volume><fpage>394</fpage><lpage>402</lpage><year>2016</year><pub-id pub-id-type="pmid">26100537</pub-id><pub-id pub-id-type="doi">10.1038/mp.2015.84</pub-id></element-citation></ref>
<ref id="b38-BR-21-5-01856"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lane</surname><given-names>DA</given-names></name><name><surname>Lessard</surname><given-names>AA</given-names></name><name><surname>Chan</surname><given-names>J</given-names></name><name><surname>Colago</surname><given-names>EE</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Schlussman</surname><given-names>SD</given-names></name><name><surname>Kreek</surname><given-names>MJ</given-names></name><name><surname>Pickel</surname><given-names>VM</given-names></name></person-group><article-title>Region-specific changes in the subcellular distribution of AMPA receptor GluR1 subunit in the rat ventral tegmental area after acute or chronic morphine administration</article-title><source>J Neurosci</source><volume>28</volume><fpage>9670</fpage><lpage>9681</lpage><year>2008</year><pub-id pub-id-type="pmid">18815253</pub-id><pub-id pub-id-type="doi">10.1523/JNEUROSCI.2151-08.2008</pub-id></element-citation></ref>
<ref id="b39-BR-21-5-01856"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Billa</surname><given-names>SK</given-names></name><name><surname>Sinha</surname><given-names>N</given-names></name><name><surname>Rudrabhatla</surname><given-names>SR</given-names></name><name><surname>Mor&#x00F3;n</surname><given-names>JA</given-names></name></person-group><article-title>Extinction of morphine-dependent conditioned behavior is associated with increased phosphorylation of the GluR1 subunit of AMPA receptors at hippocampal synapses</article-title><source>Eur J Neurosci</source><volume>29</volume><fpage>55</fpage><lpage>64</lpage><year>2009</year><pub-id pub-id-type="pmid">19077125</pub-id><pub-id pub-id-type="doi">10.1111/j.1460-9568.2008.06560.x</pub-id></element-citation></ref>
<ref id="b40-BR-21-5-01856"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cai</surname><given-names>YQ</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Hou</surname><given-names>YY</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Xie</surname><given-names>J</given-names></name><name><surname>Pan</surname><given-names>ZZ</given-names></name></person-group><article-title>Central amygdala GluA1 facilitates associative learning of opioid reward</article-title><source>J Neurosci</source><volume>33</volume><fpage>1577</fpage><lpage>1588</lpage><year>2013</year><pub-id pub-id-type="pmid">23345231</pub-id><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1749-12.2013</pub-id></element-citation></ref>
<ref id="b41-BR-21-5-01856"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>G</given-names></name><name><surname>Zhou</surname><given-names>K</given-names></name><name><surname>Zhu</surname><given-names>Y</given-names></name></person-group><article-title>A conditioned place preference protocol for measuring incubation of craving in rats</article-title><source>J Vis Exp</source><year>2018</year><pub-id pub-id-type="pmid">30474645</pub-id><pub-id pub-id-type="doi">10.3791/58384</pub-id></element-citation></ref>
<ref id="b42-BR-21-5-01856"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tzschentke</surname><given-names>TM</given-names></name></person-group><article-title>Measuring reward with the conditioned place preference (CPP) paradigm: Update of the last decade</article-title><source>Addict Biol</source><volume>12</volume><fpage>227</fpage><lpage>462</lpage><year>2007</year><pub-id pub-id-type="pmid">17678505</pub-id><pub-id pub-id-type="doi">10.1111/j.1369-1600.2007.00070.x</pub-id></element-citation></ref>
<ref id="b43-BR-21-5-01856"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>XJ</given-names></name><name><surname>Zhang</surname><given-names>JJ</given-names></name><name><surname>Yu</surname><given-names>LC</given-names></name></person-group><article-title>GluR2-3Y inhibits the acquisition and reinstatement of morphine-induced conditioned place preference in rats</article-title><source>Neurosci Bull</source><volume>32</volume><fpage>177</fpage><lpage>182</lpage><year>2016</year><pub-id pub-id-type="pmid">26924808</pub-id><pub-id pub-id-type="doi">10.1007/s12264-016-0018-9</pub-id></element-citation></ref>
<ref id="b44-BR-21-5-01856"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tzschentke</surname><given-names>TM</given-names></name></person-group><article-title>Measuring reward with the conditioned place preference paradigm: A comprehensive review of drug effects, recent progress and new issues</article-title><source>Prog Neurobiol</source><volume>56</volume><fpage>613</fpage><lpage>672</lpage><year>1998</year><pub-id pub-id-type="pmid">9871940</pub-id><pub-id pub-id-type="doi">10.1016/s0301-0082(98)00060-4</pub-id></element-citation></ref>
<ref id="b45-BR-21-5-01856"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Bey</surname><given-names>AL</given-names></name><name><surname>Katz</surname><given-names>BM</given-names></name><name><surname>Badea</surname><given-names>A</given-names></name><name><surname>Kim</surname><given-names>N</given-names></name><name><surname>David</surname><given-names>LK</given-names></name><name><surname>Duffney</surname><given-names>LJ</given-names></name><name><surname>Kumar</surname><given-names>S</given-names></name><name><surname>Mague</surname><given-names>SD</given-names></name><name><surname>Hulbert</surname><given-names>SW</given-names></name><etal/></person-group><article-title>Altered mGluR5-Homer scaffolds and corticostriatal connectivity in a Shank3 complete knockout model of autism</article-title><source>Nat Commun</source><volume>7</volume><issue>11459</issue><year>2016</year><pub-id pub-id-type="pmid">27161151</pub-id><pub-id pub-id-type="doi">10.1038/ncomms11459</pub-id></element-citation></ref>
<ref id="b46-BR-21-5-01856"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dom&#x00ED;nguez-Salazar</surname><given-names>E</given-names></name><name><surname>Naser</surname><given-names>HF</given-names></name><name><surname>Vel&#x00E1;zquez-Moctezuma</surname><given-names>J</given-names></name></person-group><article-title>D1-like antagonist blocks conditioned place preference induced by ejaculation in male rats</article-title><source>Behav Brain Res</source><volume>269</volume><fpage>15</fpage><lpage>19</lpage><year>2014</year><pub-id pub-id-type="pmid">24768642</pub-id><pub-id pub-id-type="doi">10.1016/j.bbr.2014.04.026</pub-id></element-citation></ref>
<ref id="b47-BR-21-5-01856"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>SL</given-names></name><name><surname>Moldow</surname><given-names>RL</given-names></name><name><surname>House</surname><given-names>SD</given-names></name><name><surname>Zadina</surname><given-names>JE</given-names></name></person-group><article-title>Morphine affects the brain-immune axis by modulating an interleukin-1 beta dependent pathway</article-title><source>Adv Exp Med Biol</source><volume>402</volume><fpage>35</fpage><lpage>42</lpage><year>1996</year><pub-id pub-id-type="pmid">8787641</pub-id><pub-id pub-id-type="doi">10.1007/978-1-4613-0407-4_6</pub-id></element-citation></ref>
<ref id="b48-BR-21-5-01856"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Graf</surname><given-names>JA</given-names></name><name><surname>Patel</surname><given-names>JA</given-names></name><name><surname>Chang</surname><given-names>SL</given-names></name></person-group><article-title>Chronic exposure to morphine, but not ethanol, attenuates the expression of interleukin-1 beta converting enzyme in rat spleen</article-title><source>Immunol Lett</source><volume>58</volume><fpage>153</fpage><lpage>157</lpage><year>1997</year><pub-id pub-id-type="pmid">9293396</pub-id><pub-id pub-id-type="doi">10.1016/s0165-2478(97)00042-4</pub-id></element-citation></ref>
<ref id="b49-BR-21-5-01856"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>House</surname><given-names>SD</given-names></name><name><surname>Mao</surname><given-names>X</given-names></name><name><surname>Wu</surname><given-names>G</given-names></name><name><surname>Espinelli</surname><given-names>D</given-names></name><name><surname>Li</surname><given-names>WX</given-names></name><name><surname>Chang</surname><given-names>SL</given-names></name></person-group><article-title>Chronic morphine potentiates the inflammatory response by disrupting interleukin-1beta modulation of the hypothalamic-pituitary-adrenal axis</article-title><source>J Neuroimmunol</source><volume>118</volume><fpage>277</fpage><lpage>285</lpage><year>2001</year><pub-id pub-id-type="pmid">11498262</pub-id><pub-id pub-id-type="doi">10.1016/s0165-5728(01)00337-x</pub-id></element-citation></ref>
<ref id="b50-BR-21-5-01856"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lobo</surname><given-names>MK</given-names></name><name><surname>Covington</surname><given-names>HE III</given-names></name><name><surname>Chaudhury</surname><given-names>D</given-names></name><name><surname>Friedman</surname><given-names>AK</given-names></name><name><surname>Sun</surname><given-names>H</given-names></name><name><surname>Damez-Werno</surname><given-names>D</given-names></name><name><surname>Dietz</surname><given-names>DM</given-names></name><name><surname>Zaman</surname><given-names>S</given-names></name><name><surname>Koo</surname><given-names>JW</given-names></name><name><surname>Kennedy</surname><given-names>PJ</given-names></name><etal/></person-group><article-title>Cell type-specific loss of BDNF signaling mimics optogenetic control of cocaine reward</article-title><source>Science</source><volume>330</volume><fpage>385</fpage><lpage>390</lpage><year>2010</year><pub-id pub-id-type="pmid">20947769</pub-id><pub-id pub-id-type="doi">10.1126/science.1188472</pub-id></element-citation></ref>
<ref id="b51-BR-21-5-01856"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ocasio</surname><given-names>FM</given-names></name><name><surname>Jiang</surname><given-names>Y</given-names></name><name><surname>House</surname><given-names>SD</given-names></name><name><surname>Chang</surname><given-names>SL</given-names></name></person-group><article-title>Chronic morphine accelerates the progression of lipopolysaccharide-induced sepsis to septic shock</article-title><source>J Neuroimmunol</source><volume>149</volume><fpage>90</fpage><lpage>100</lpage><year>2004</year><pub-id pub-id-type="pmid">15020069</pub-id><pub-id pub-id-type="doi">10.1016/j.jneuroim.2003.12.016</pub-id></element-citation></ref>
<ref id="b52-BR-21-5-01856"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zadina</surname><given-names>JE</given-names></name><name><surname>Kastin</surname><given-names>AJ</given-names></name><name><surname>Harrison</surname><given-names>LM</given-names></name><name><surname>Ge</surname><given-names>LJ</given-names></name><name><surname>Chang</surname><given-names>SL</given-names></name></person-group><article-title>Opiate receptor changes after chronic exposure to agonists and antagonists</article-title><source>Ann N Y Acad Sci</source><volume>757</volume><fpage>353</fpage><lpage>361</lpage><year>1995</year><pub-id pub-id-type="pmid">7611692</pub-id><pub-id pub-id-type="doi">10.1111/j.1749-6632.1995.tb17493.x</pub-id></element-citation></ref>
<ref id="b53-BR-21-5-01856"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Askari</surname><given-names>N</given-names></name><name><surname>Mousavi</surname><given-names>A</given-names></name><name><surname>Vaez-Mahdavi</surname><given-names>MR</given-names></name></person-group><article-title>Maternal deprivation effect on morphine-induced CPP is related to changes in opioid receptors in selected rat brain regions (hippocampus, prefrontal cortex, and nucleus accumbens)</article-title><source>Behav Processes</source><volume>197</volume><issue>104607</issue><year>2022</year><pub-id pub-id-type="pmid">35218881</pub-id><pub-id pub-id-type="doi">10.1016/j.beproc.2022.104607</pub-id></element-citation></ref>
<ref id="b54-BR-21-5-01856"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodgers</surname><given-names>HM</given-names></name><name><surname>Lim</surname><given-names>SA</given-names></name><name><surname>Yow</surname><given-names>J</given-names></name><name><surname>Dinkins</surname><given-names>ML</given-names></name><name><surname>Patton</surname><given-names>R</given-names></name><name><surname>Clemens</surname><given-names>S</given-names></name><name><surname>Brewer</surname><given-names>KL</given-names></name></person-group><article-title>Dopamine D<sub>1</sub> or D<sub>3</sub> receptor modulators prevent morphine tolerance and reduce opioid withdrawal symptoms</article-title><source>Pharmacol Biochem Behav</source><volume>194</volume><issue>172935</issue><year>2020</year><pub-id pub-id-type="pmid">32335101</pub-id><pub-id pub-id-type="doi">10.1016/j.pbb.2020.172935</pub-id></element-citation></ref>
<ref id="b55-BR-21-5-01856"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>LW</given-names></name><name><surname>Lu</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>XH</given-names></name><name><surname>Fu</surname><given-names>SK</given-names></name><name><surname>Li</surname><given-names>Q</given-names></name><name><surname>Lin</surname><given-names>FQ</given-names></name></person-group><article-title>Neuronal apoptosis in morphine addiction and its molecular mechanism</article-title><source>Int J Clin Exp Med</source><volume>6</volume><fpage>540</fpage><lpage>545</lpage><year>2013</year><pub-id pub-id-type="pmid">23936592</pub-id></element-citation></ref>
<ref id="b56-BR-21-5-01856"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Papaleo</surname><given-names>F</given-names></name><name><surname>Contarino</surname><given-names>A</given-names></name></person-group><article-title>Gender- and morphine dose-linked expression of spontaneous somatic opiate withdrawal in mice</article-title><source>Behav Brain Res</source><volume>170</volume><fpage>110</fpage><lpage>118</lpage><year>2006</year><pub-id pub-id-type="pmid">16580078</pub-id><pub-id pub-id-type="doi">10.1016/j.bbr.2006.02.009</pub-id></element-citation></ref>
<ref id="b57-BR-21-5-01856"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rahmati</surname><given-names>B</given-names></name><name><surname>Beik</surname><given-names>A</given-names></name></person-group><article-title>Prevention of morphine dependence and tolerance by Nepeta menthoides was accompanied by attenuation of Nitric oxide overproduction in male mice</article-title><source>J Ethnopharmacol</source><volume>199</volume><fpage>39</fpage><lpage>51</lpage><year>2017</year><pub-id pub-id-type="pmid">28130112</pub-id><pub-id pub-id-type="doi">10.1016/j.jep.2017.01.032</pub-id></element-citation></ref>
<ref id="b58-BR-21-5-01856"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koek</surname><given-names>W</given-names></name></person-group><article-title>Morphine-induced conditioned place preference and effects of morphine pre-exposure in adolescent and adult male C57BL/6J mice</article-title><source>Psychopharmacology (Berl)</source><volume>233</volume><fpage>2015</fpage><lpage>2024</lpage><year>2016</year><pub-id pub-id-type="pmid">25066361</pub-id><pub-id pub-id-type="doi">10.1007/s00213-014-3695-y</pub-id></element-citation></ref>
<ref id="b59-BR-21-5-01856"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Kshatriya</surname><given-names>D</given-names></name><name><surname>Bello</surname><given-names>NT</given-names></name></person-group><article-title>Weight-gain propensity and morphine withdrawal alters locomotor behavior and regional norepinephrine-related gene expression in male and female mice</article-title><source>Pharmacol Biochem Behav</source><volume>213</volume><issue>173329</issue><year>2022</year><pub-id pub-id-type="pmid">35007656</pub-id><pub-id pub-id-type="doi">10.1016/j.pbb.2022.173329</pub-id></element-citation></ref>
<ref id="b60-BR-21-5-01856"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Madayag</surname><given-names>AC</given-names></name><name><surname>Gomez</surname><given-names>D</given-names></name><name><surname>Anderson</surname><given-names>EM</given-names></name><name><surname>Ingebretson</surname><given-names>AE</given-names></name><name><surname>Thomas</surname><given-names>MJ</given-names></name><name><surname>Hearing</surname><given-names>MC</given-names></name></person-group><article-title>Cell-type and region-specific nucleus accumbens AMPAR plasticity associated with morphine reward, reinstatement, and spontaneous withdrawal</article-title><source>Brain Struct Funct</source><volume>224</volume><fpage>2311</fpage><lpage>2324</lpage><year>2019</year><pub-id pub-id-type="pmid">31201496</pub-id><pub-id pub-id-type="doi">10.1007/s00429-019-01903-y</pub-id></element-citation></ref>
<ref id="b61-BR-21-5-01856"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McDevitt</surname><given-names>DS</given-names></name><name><surname>McKendrick</surname><given-names>G</given-names></name><name><surname>Graziane</surname><given-names>NM</given-names></name></person-group><article-title>Anterior cingulate cortex is necessary for spontaneous opioid withdrawal and withdrawal-induced hyperalgesia in male mice</article-title><source>Neuropsychopharmacology</source><volume>46</volume><fpage>1990</fpage><lpage>1999</lpage><year>2021</year><pub-id pub-id-type="pmid">34341495</pub-id><pub-id pub-id-type="doi">10.1038/s41386-021-01118-y</pub-id></element-citation></ref>
<ref id="b62-BR-21-5-01856"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakamura</surname><given-names>A</given-names></name><name><surname>Ono</surname><given-names>H</given-names></name><name><surname>Ando</surname><given-names>A</given-names></name><name><surname>Hinata</surname><given-names>M</given-names></name><name><surname>Niidome</surname><given-names>K</given-names></name><name><surname>Omachi</surname><given-names>S</given-names></name><name><surname>Sakaguchi</surname><given-names>G</given-names></name><name><surname>Shinohara</surname><given-names>S</given-names></name></person-group><article-title>Suppression of the acute upregulation of phosphorylated-extracellular regulated kinase in ventral tegmental area by a &#x00B5;-opioid receptor agonist is related to resistance to rewarding effects in a mouse model of bone cancer</article-title><source>J Pharmacol Sci</source><volume>133</volume><fpage>9</fpage><lpage>17</lpage><year>2017</year><pub-id pub-id-type="pmid">28034513</pub-id><pub-id pub-id-type="doi">10.1016/j.jphs.2016.11.004</pub-id></element-citation></ref>
<ref id="b63-BR-21-5-01856"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piccin</surname><given-names>A</given-names></name><name><surname>Contarino</surname><given-names>A</given-names></name></person-group><article-title>Long-lasting pseudo-social aggressive behavior in opiate-withdrawn mice</article-title><source>Prog Neuropsychopharmacol Biol Psychiatry</source><volume>97</volume><issue>109780</issue><year>2020</year><pub-id pub-id-type="pmid">31669507</pub-id><pub-id pub-id-type="doi">10.1016/j.pnpbp.2019.109780</pub-id></element-citation></ref>
<ref id="b64-BR-21-5-01856"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piccin</surname><given-names>A</given-names></name><name><surname>Contarino</surname><given-names>A</given-names></name></person-group><article-title>The CRF(1) receptor mediates social behavior deficits induced by opiate withdrawal</article-title><source>J Neurosci Res</source><volume>100</volume><fpage>309</fpage><lpage>321</lpage><year>2022</year><pub-id pub-id-type="pmid">32725663</pub-id><pub-id pub-id-type="doi">10.1002/jnr.24697</pub-id></element-citation></ref>
<ref id="b65-BR-21-5-01856"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Varshneya</surname><given-names>NB</given-names></name><name><surname>Walentiny</surname><given-names>DM</given-names></name><name><surname>Stevens</surname><given-names>DL</given-names></name><name><surname>Walker</surname><given-names>TD</given-names></name><name><surname>Akinfiresoye</surname><given-names>LR</given-names></name><name><surname>Beardsley</surname><given-names>PM</given-names></name></person-group><article-title>Structurally diverse fentanyl analogs yield differential locomotor activities in mice</article-title><source>Pharmacol Biochem Behav</source><volume>222</volume><issue>173496</issue><year>2023</year><pub-id pub-id-type="pmid">36435268</pub-id><pub-id pub-id-type="doi">10.1016/j.pbb.2022.173496</pub-id></element-citation></ref>
<ref id="b66-BR-21-5-01856"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalvass</surname><given-names>JC</given-names></name><name><surname>Olson</surname><given-names>ER</given-names></name><name><surname>Cassidy</surname><given-names>MP</given-names></name><name><surname>Selley</surname><given-names>DE</given-names></name><name><surname>Pollack</surname><given-names>GM</given-names></name></person-group><article-title>Pharmacokinetics and pharmacodynamics of seven opioids in P-glycoprotein-competent mice: Assessment of unbound brain EC50,u and correlation of in vitro, preclinical, and clinical data</article-title><source>J Pharmacol Exp Ther</source><volume>323</volume><fpage>346</fpage><lpage>355</lpage><year>2007</year><pub-id pub-id-type="pmid">17646430</pub-id><pub-id pub-id-type="doi">10.1124/jpet.107.119560</pub-id></element-citation></ref>
<ref id="b67-BR-21-5-01856"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Melzacka</surname><given-names>M</given-names></name></person-group><article-title>Pharmacokinetic aspects of some behavioral effects of psychotropic drugs</article-title><source>Pol J Pharmacol Pharm</source><volume>36</volume><fpage>117</fpage><lpage>136</lpage><year>1984</year><pub-id pub-id-type="pmid">6147827</pub-id></element-citation></ref>
<ref id="b68-BR-21-5-01856"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Regenthal</surname><given-names>R</given-names></name><name><surname>Krueger</surname><given-names>M</given-names></name><name><surname>Koeppel</surname><given-names>C</given-names></name><name><surname>Preiss</surname><given-names>R</given-names></name></person-group><article-title>Drug levels: Therapeutic and toxic serum/plasma concentrations of common drugs</article-title><source>J Clin Monit Comput</source><volume>15</volume><fpage>529</fpage><lpage>544</lpage><year>1999</year><pub-id pub-id-type="pmid">12578052</pub-id><pub-id pub-id-type="doi">10.1023/a:1009935116877</pub-id></element-citation></ref>
<ref id="b69-BR-21-5-01856"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sulimai</surname><given-names>NH</given-names></name><name><surname>Ko</surname><given-names>JC</given-names></name><name><surname>Jones-Hall</surname><given-names>YL</given-names></name><name><surname>Weng</surname><given-names>HY</given-names></name><name><surname>Deng</surname><given-names>M</given-names></name><name><surname>Breur</surname><given-names>GJ</given-names></name><name><surname>Knipp</surname><given-names>GT</given-names></name></person-group><article-title>Evaluation of 25&#x0025; poloxamer as a slow release carrier for morphine in a rat model</article-title><source>Front Vet Sci</source><volume>5</volume><issue>19</issue><year>2018</year><pub-id pub-id-type="pmid">29594153</pub-id><pub-id pub-id-type="doi">10.3389/fvets.2018.00019</pub-id></element-citation></ref>
<ref id="b70-BR-21-5-01856"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santos-Vera</surname><given-names>B</given-names></name><name><surname>Vaquer-Alicea</surname><given-names>ADC</given-names></name><name><surname>Maria-Rios</surname><given-names>CE</given-names></name><name><surname>Montiel-Ramos</surname><given-names>A</given-names></name><name><surname>Ramos-Cardona</surname><given-names>A</given-names></name><name><surname>V&#x00E1;zquez-Torres</surname><given-names>R</given-names></name><name><surname>Sanabria</surname><given-names>P</given-names></name><name><surname>Jim&#x00E9;nez-Rivera</surname><given-names>CA</given-names></name></person-group><article-title>Protein and surface expression of HCN2 and HCN4 subunits in mesocorticolimbic areas after cocaine sensitization</article-title><source>Neurochem Int</source><volume>125</volume><fpage>91</fpage><lpage>98</lpage><year>2019</year><pub-id pub-id-type="pmid">30794847</pub-id><pub-id pub-id-type="doi">10.1016/j.neuint.2019.02.004</pub-id></element-citation></ref>
<ref id="b71-BR-21-5-01856"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>DN</given-names></name><name><surname>Song</surname><given-names>R</given-names></name><name><surname>Zhang</surname><given-names>SZ</given-names></name><name><surname>Wu</surname><given-names>N</given-names></name><name><surname>Li</surname><given-names>J</given-names></name></person-group><article-title>Nucleus accumbens hyperpolarization-activated cyclic nucleotide-gated channels modulate methamphetamine self-administration in rats</article-title><source>Psychopharmacology (Berl)</source><volume>233</volume><fpage>3017</fpage><lpage>3029</lpage><year>2016</year><pub-id pub-id-type="pmid">27329413</pub-id><pub-id pub-id-type="doi">10.1007/s00213-016-4349-z</pub-id></element-citation></ref>
<ref id="b72-BR-21-5-01856"><label>72</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caruso Brown</surname><given-names>AE</given-names></name></person-group><article-title>Treating addiction as a terminal disease</article-title><source>N Engl J Med</source><volume>382</volume><fpage>207</fpage><lpage>209</lpage><year>2020</year><pub-id pub-id-type="pmid">31940697</pub-id><pub-id pub-id-type="doi">10.1056/NEJMp1909298</pub-id></element-citation></ref>
<ref id="b73-BR-21-5-01856"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mu</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Yu</surname><given-names>H</given-names></name><name><surname>Vickstrom</surname><given-names>CR</given-names></name><name><surname>Friedman</surname><given-names>V</given-names></name><name><surname>Kelly</surname><given-names>TJ</given-names></name><name><surname>Hu</surname><given-names>Y</given-names></name><name><surname>Su</surname><given-names>W</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Mantsch</surname><given-names>JR</given-names></name><name><surname>Liu</surname><given-names>QS</given-names></name></person-group><article-title>cAMP-mediated upregulation of HCN channels in VTA dopamine neurons promotes cocaine reinforcement</article-title><source>Mol Psychiatry</source><volume>28</volume><fpage>3930</fpage><lpage>3942</lpage><year>2023</year><pub-id pub-id-type="pmid">37845497</pub-id><pub-id pub-id-type="doi">10.1038/s41380-023-02290-x</pub-id></element-citation></ref>
<ref id="b74-BR-21-5-01856"><label>74</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Settley</surname><given-names>C</given-names></name></person-group><article-title>The physical and psychological wellbeing of caregivers of individuals suffering from substance addiction</article-title><source>Arch Psychiatr Nurs</source><volume>34</volume><fpage>107</fpage><lpage>109</lpage><year>2020</year><pub-id pub-id-type="pmid">32513458</pub-id><pub-id pub-id-type="doi">10.1016/j.apnu.2020.03.007</pub-id></element-citation></ref>
<ref id="b75-BR-21-5-01856"><label>75</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiao</surname><given-names>ZW</given-names></name><name><surname>Cao</surname><given-names>CY</given-names></name><name><surname>Wang</surname><given-names>ZX</given-names></name><name><surname>Li</surname><given-names>JX</given-names></name><name><surname>Liao</surname><given-names>HY</given-names></name><name><surname>Zhang</surname><given-names>XX</given-names></name></person-group><article-title>Changes of dopamine transporter function in striatum during acute morphine addiction and its abstinence in rhesus monkey</article-title><source>Chin Med J (Engl)</source><volume>119</volume><fpage>1802</fpage><lpage>1807</lpage><year>2006</year><pub-id pub-id-type="pmid">17097035</pub-id></element-citation></ref>
<ref id="b76-BR-21-5-01856"><label>76</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aramjoo</surname><given-names>H</given-names></name><name><surname>Riahi-Zanjani</surname><given-names>B</given-names></name><name><surname>Farkhondeh</surname><given-names>T</given-names></name><name><surname>Forouzanfar</surname><given-names>F</given-names></name><name><surname>Sadeghi</surname><given-names>M</given-names></name></person-group><article-title>Modulatory effect of opioid administration on the activity of cholinesterase enzyme: A systematic review of mice/rat models</article-title><source>Environ Sci Pollut Res Int</source><volume>28</volume><fpage>52675</fpage><lpage>52688</lpage><year>2021</year><pub-id pub-id-type="pmid">34453251</pub-id><pub-id pub-id-type="doi">10.1007/s11356-021-16044-1</pub-id></element-citation></ref>
<ref id="b77-BR-21-5-01856"><label>77</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Djabirska</surname><given-names>I</given-names></name><name><surname>Delaval</surname><given-names>L</given-names></name><name><surname>Tromme</surname><given-names>A</given-names></name><name><surname>Blomet</surname><given-names>J</given-names></name><name><surname>Desmecht</surname><given-names>D</given-names></name><name><surname>Van Laere</surname><given-names>AS</given-names></name></person-group><article-title>Longitudinal quantitative assessment of TMEV-IDD-induced MS phenotypes in two inbred mouse strains using automated video tracking technology</article-title><source>Exp Neurol</source><volume>379</volume><issue>114851</issue><year>2024</year><pub-id pub-id-type="pmid">38876197</pub-id><pub-id pub-id-type="doi">10.1016/j.expneurol.2024.114851</pub-id></element-citation></ref>
<ref id="b78-BR-21-5-01856"><label>78</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kulbeth</surname><given-names>HJ</given-names></name><name><surname>Fukuda</surname><given-names>S</given-names></name><name><surname>Brents</surname><given-names>LK</given-names></name></person-group><article-title>Automated quantification of opioid withdrawal in neonatal rat pups using Ethovision&#x00AE; XT software</article-title><source>Neurotoxicol Teratol</source><volume>84</volume><issue>106959</issue><year>2021</year><pub-id pub-id-type="pmid">33529734</pub-id><pub-id pub-id-type="doi">10.1016/j.ntt.2021.106959</pub-id></element-citation></ref>
<ref id="b79-BR-21-5-01856"><label>79</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richmond-Hacham</surname><given-names>B</given-names></name><name><surname>Tseitlin</surname><given-names>L</given-names></name><name><surname>Bikovski</surname><given-names>L</given-names></name><name><surname>Pick</surname><given-names>CG</given-names></name></person-group><article-title>Investigation of mild traumatic brain injury home cage behavior: The home cage assay advantages</article-title><source>J Neurotrauma</source><volume>41</volume><fpage>e1780</fpage><lpage>e1792</lpage><year>2024</year><pub-id pub-id-type="pmid">38517091</pub-id><pub-id pub-id-type="doi">10.1089/neu.2023.0459</pub-id></element-citation></ref>
<ref id="b80-BR-21-5-01856"><label>80</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Timotius</surname><given-names>IK</given-names></name><name><surname>Roelofs</surname><given-names>RF</given-names></name><name><surname>Richmond-Hacham</surname><given-names>B</given-names></name><name><surname>Noldus</surname><given-names>LPJJ</given-names></name><name><surname>von H&#x00F6;rsten</surname><given-names>S</given-names></name><name><surname>Bikovski</surname><given-names>L</given-names></name></person-group><article-title>CatWalk XT gait parameters: A review of reported parameters in pre-clinical studies of multiple central nervous system and peripheral nervous system disease models</article-title><source>Front Behav Neurosci</source><volume>17</volume><issue>1147784</issue><year>2023</year><pub-id pub-id-type="pmid">37351154</pub-id><pub-id pub-id-type="doi">10.3389/fnbeh.2023.1147784</pub-id></element-citation></ref>
<ref id="b81-BR-21-5-01856"><label>81</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watkins</surname><given-names>J</given-names></name><name><surname>Ghosh</surname><given-names>A</given-names></name><name><surname>Keerie</surname><given-names>AFA</given-names></name><name><surname>Alix</surname><given-names>JJP</given-names></name><name><surname>Mead</surname><given-names>RJ</given-names></name><name><surname>Sreedharan</surname><given-names>J</given-names></name></person-group><article-title>Female sex mitigates motor and behavioural phenotypes in TDP-43<sup>Q331K</sup> knock-in mice</article-title><source>Sci Rep</source><volume>10</volume><issue>19220</issue><year>2020</year><pub-id pub-id-type="pmid">33154447</pub-id><pub-id pub-id-type="doi">10.1038/s41598-020-76070-w</pub-id></element-citation></ref>
<ref id="b82-BR-21-5-01856"><label>82</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lebedev</surname><given-names>IV</given-names></name><name><surname>Pleskacheva</surname><given-names>MG</given-names></name><name><surname>Anokhin</surname><given-names>KV</given-names></name></person-group><article-title>C57BL/6 mice open field behaviour qualitatively depends on arena size</article-title><source>Zh Vyssh Nerv Deiat Im I P Pavlova</source><volume>62</volume><fpage>485</fpage><lpage>496</lpage><year>2012</year><pub-id pub-id-type="pmid">23035565</pub-id><comment>(In Russian)</comment></element-citation></ref>
<ref id="b83-BR-21-5-01856"><label>83</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Novati</surname><given-names>A</given-names></name><name><surname>Manfr&#x00E9;</surname><given-names>G</given-names></name><name><surname>Flunkert</surname><given-names>S</given-names></name><name><surname>Van der Harst</surname><given-names>JE</given-names></name><name><surname>Homberg</surname><given-names>JR</given-names></name><name><surname>Wronski</surname><given-names>R</given-names></name><name><surname>Nguyen</surname><given-names>HP</given-names></name></person-group><article-title>Validation of behavioral phenotypes in the BACHD rat model</article-title><source>Behav Brain Res</source><volume>393</volume><issue>112783</issue><year>2020</year><pub-id pub-id-type="pmid">32574646</pub-id><pub-id pub-id-type="doi">10.1016/j.bbr.2020.112783</pub-id></element-citation></ref>
<ref id="b84-BR-21-5-01856"><label>84</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Braw</surname><given-names>Y</given-names></name><name><surname>Malkesman</surname><given-names>O</given-names></name><name><surname>Dagan</surname><given-names>M</given-names></name><name><surname>Bercovich</surname><given-names>A</given-names></name><name><surname>Lavi-Avnon</surname><given-names>Y</given-names></name><name><surname>Schroeder</surname><given-names>M</given-names></name><name><surname>Overstreet</surname><given-names>DH</given-names></name><name><surname>Weller</surname><given-names>A</given-names></name></person-group><article-title>Anxiety-like behaviors in pre-pubertal rats of the Flinders Sensitive Line (FSL) and Wistar-Kyoto (WKY) animal models of depression</article-title><source>Behav Brain Res</source><volume>167</volume><fpage>261</fpage><lpage>269</lpage><year>2006</year><pub-id pub-id-type="pmid">16271773</pub-id><pub-id pub-id-type="doi">10.1016/j.bbr.2005.09.013</pub-id></element-citation></ref>
<ref id="b85-BR-21-5-01856"><label>85</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Medvedev</surname><given-names>IO</given-names></name><name><surname>Malyshkin</surname><given-names>AA</given-names></name><name><surname>Belozertseva</surname><given-names>IV</given-names></name><name><surname>Sukhotina</surname><given-names>IA</given-names></name><name><surname>Sevostianova</surname><given-names>NY</given-names></name><name><surname>Aliev</surname><given-names>K</given-names></name><name><surname>Zvartau</surname><given-names>EE</given-names></name><name><surname>Parsons</surname><given-names>CG</given-names></name><name><surname>Danysz</surname><given-names>W</given-names></name><name><surname>Bespalov</surname><given-names>AY</given-names></name></person-group><article-title>Effects of low-affinity NMDA receptor channel blockers in two rat models of chronic pain</article-title><source>Neuropharmacology</source><volume>47</volume><fpage>175</fpage><lpage>183</lpage><year>2004</year><pub-id pub-id-type="pmid">15223296</pub-id><pub-id pub-id-type="doi">10.1016/j.neuropharm.2004.01.019</pub-id></element-citation></ref>
<ref id="b86-BR-21-5-01856"><label>86</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuan</surname><given-names>X</given-names></name><name><surname>Devine</surname><given-names>DP</given-names></name></person-group><article-title>The role of anxiety in vulnerability for self-injurious behaviour: studies in a rodent model</article-title><source>Behav Brain Res</source><volume>311</volume><fpage>201</fpage><lpage>209</lpage><year>2016</year><pub-id pub-id-type="pmid">27217100</pub-id><pub-id pub-id-type="doi">10.1016/j.bbr.2016.05.041</pub-id></element-citation></ref>
<ref id="b87-BR-21-5-01856"><label>87</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Le</surname><given-names>T</given-names></name><name><surname>Xia</surname><given-names>M</given-names></name><name><surname>Jia</surname><given-names>M</given-names></name><name><surname>Sarkar</surname><given-names>N</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Wynn</surname><given-names>GH</given-names></name><name><surname>Ursano</surname><given-names>RJ</given-names></name><name><surname>Choi</surname><given-names>KH</given-names></name></person-group><article-title>Association between initial morphine intake and body weight change, acoustic startle reflex and drug seeking in rats</article-title><source>Psychopharmacology (Berl)</source><volume>231</volume><fpage>4569</fpage><lpage>4577</lpage><year>2014</year><pub-id pub-id-type="pmid">24819733</pub-id><pub-id pub-id-type="doi">10.1007/s00213-014-3606-2</pub-id></element-citation></ref>
<ref id="b88-BR-21-5-01856"><label>88</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kon</surname><given-names>R</given-names></name><name><surname>Ikarashi</surname><given-names>N</given-names></name><name><surname>Hayakawa</surname><given-names>A</given-names></name><name><surname>Haga</surname><given-names>Y</given-names></name><name><surname>Fueki</surname><given-names>A</given-names></name><name><surname>Kusunoki</surname><given-names>Y</given-names></name><name><surname>Tajima</surname><given-names>M</given-names></name><name><surname>Ochiai</surname><given-names>W</given-names></name><name><surname>Machida</surname><given-names>Y</given-names></name><name><surname>Sugiyama</surname><given-names>K</given-names></name></person-group><article-title>Morphine-induced constipation develops with increased aquaporin-3 expression in the colon via increased serotonin secretion</article-title><source>Toxicol Sci</source><volume>145</volume><fpage>337</fpage><lpage>347</lpage><year>2015</year><pub-id pub-id-type="pmid">25766885</pub-id><pub-id pub-id-type="doi">10.1093/toxsci/kfv055</pub-id></element-citation></ref>
<ref id="b89-BR-21-5-01856"><label>89</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deroche</surname><given-names>V</given-names></name><name><surname>Piazza</surname><given-names>PV</given-names></name><name><surname>Casolini</surname><given-names>P</given-names></name><name><surname>Maccari</surname><given-names>S</given-names></name><name><surname>Le Moal</surname><given-names>M</given-names></name><name><surname>Simon</surname><given-names>H</given-names></name></person-group><article-title>Stress-induced sensitization to amphetamine and morphine psychomotor effects depend on stress-induced corticosterone secretion</article-title><source>Brain Res</source><volume>598</volume><fpage>343</fpage><lpage>348</lpage><year>1992</year><pub-id pub-id-type="pmid">1486498</pub-id><pub-id pub-id-type="doi">10.1016/0006-8993(92)90205-n</pub-id></element-citation></ref>
<ref id="b90-BR-21-5-01856"><label>90</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yunusa</surname><given-names>S</given-names></name><name><surname>M&#x00FC;ller</surname><given-names>CP</given-names></name><name><surname>Hassan</surname><given-names>Z</given-names></name></person-group><article-title>Mitragynine (Kratom)-Withdrawal behaviour and cognitive impairments can be ameliorated by an epigenetic mechanism</article-title><source>Br J Pharmacol</source><volume>181</volume><fpage>2070</fpage><lpage>2084</lpage><year>2024</year><pub-id pub-id-type="pmid">38523471</pub-id><pub-id pub-id-type="doi">10.1111/bph.16352</pub-id></element-citation></ref>
</ref-list>
</back>
<floats-group>
<fig id="f1-BR-21-5-01856" position="float">
<label>Figure 1</label>
<caption><p>Body weight changes during morphine addiction modeling in rats. Body weight changes over the 14-day modeling period for rats in the morphine and control groups. On day 14, the average body weight of control rats was 233.6&#x00B1;8.0 g (maximum, 287.7 g), while that of rats in the morphine group was 206.2&#x00B1;3.4 g (maximum, 222.0 g). There was a statistically significant difference in the rate of body weight gain for rats in the morphine group compared with the control group (n=15, day 14, z=2.717, P=0.0057). <sup>&#x002A;</sup>P&#x003C;0.05.</p></caption>
<graphic xlink:href="br-21-05-01856-g00.tif" />
</fig>
<fig id="f2-BR-21-5-01856" position="float">
<label>Figure 2</label>
<caption><p>Changes in thermal nociceptive tolerance time during morphine addiction modeling in rats. Thermal nociceptive tolerance time over 14 days for control rats and rats in the morphine group. The gap in thermal nociceptive tolerance time before and after morphine injection was more pronounced in the morphine group compared with the control group before and after saline injection (n=15, U=74.4, P=0.039). <sup>&#x002A;</sup>P&#x003C;0.05.</p></caption>
<graphic xlink:href="br-21-05-01856-g01.tif" />
</fig>
<fig id="f3-BR-21-5-01856" position="float">
<label>Figure 3</label>
<caption><p>Comparison of white box time in CPP experiment before and after morphine addiction modeling. Comparative analysis of the time spent in the white box during the CPP experiment between rats in the morphine group and the control group. The comparisons include differences in white box time before morphine addiction (day 4) and after morphine addiction (day 14), and the variation in white box time for rats in the morphine group before and after addiction. Prior to morphine addiction (day 4), no significant difference was observed in the white box time between rats in the morphine group and the control group (n=10, &#x03C7;&#x00B2;=0.2, P=0.64). However, after morphine addiction (day 14), a significant difference in white box time was evident between the two groups (n=10, &#x03C7;&#x00B2;=134.8, P&#x003C;0.001). Additionally, a significant difference in white box time was identified in the morphine group between day 4 and day 14 (n=10, &#x03C7;&#x00B2;=170.8, P&#x003C;0.001). <sup>&#x002A;&#x002A;&#x002A;</sup>P&#x003C;0.001. CPP, conditioned place preference; ns, not significant.</p></caption>
<graphic xlink:href="br-21-05-01856-g02.tif" />
</fig>
<fig id="f4-BR-21-5-01856" position="float">
<label>Figure 4</label>
<caption><p>Behavioral analysis by video coding comparing rats in the morphine group and control group. (A) No significant difference was shown in feed intake between the morphine and control groups (n=8, U=65.5, P=0.98). (B) A significant difference was shown in water intake, with the morphine group drinking less than the control group (n=8, U=17, P=0.0014). (C) A significant difference was shown in foreleg licking, with the morphine group licking less than the control group (n=8, U=27, P=0.014). (D) A significant difference was shown in hind limb licking, with the morphine group licking more than the control group (n=8, U=32, P=0.035). (E) No significant difference was shown in hind leg lifting between the morphine and control groups (n=8, U=62, P=0.082&#x003E;0.05). <sup>&#x002A;</sup>P&#x003C;0.05.</p></caption>
<graphic xlink:href="br-21-05-01856-g03.tif" />
</fig>
<fig id="f5-BR-21-5-01856" position="float">
<label>Figure 5</label>
<caption><p>Behavioral comparison between morphine and control group rats over a 9-h period using video coding. (A) Comparison of &#x2018;ball sleeping&#x2019; behavior, a significant difference was observed only during the 2:30-3:00 p.m. period (n=8, z=-2.412, P=0.0159). (B) Analysis of &#x2018;marten sleeping behavior (n=8, P=0.8&#x003E;0.05). (C) Frequency of scratching actions, a significant difference was found only during the 1:00-1:30 p.m. period (n=8, z=-1.964, P=0.0495). (D) Frequency of fur licking, a significant difference was observed only during the 3:30-4:00 p.m. period (n=8, z=-2.29, P=0.022). (E) Comparison of walking frequency, significant differences were noted during the 12:00-12:30 p.m. (n=8, z=-2.093, P=0.036) and 6:00-6:30 p.m. periods (n=8, z=2.039, P=0.0415). <sup>&#x002A;</sup>P&#x003C;0.05.</p></caption>
<graphic xlink:href="br-21-05-01856-g04.tif" />
</fig>
</floats-group>
</article>
